Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration

Published:2009-05 Issue:4 Volume:26 Page:295-320
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs & Aging

Author:

Ziemssen Focke,Grisanti Salvatore,Bartz-Schmidt Karl Ulrich,Spitzer Martin S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Reference168 articles.

1. Update on Clinical Data with Regimens Inhibiting Angiogenesis and Epidermal Growth Factor Receptor for Patients with Newly Diagnosed Metastatic Colorectal Cancer

2. Bevacizumab for the treatment of advanced non-small-cell lung cancer

3. Thumbs up for Avastin

4. Investigating the Potential of Bevacizumab in Other Indications: Metastatic Renal Cell, Non-Small Cell Lung, Pancreatic and Breast Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management;Chonnam Medical Journal;2023

2. The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab;Biomolecules;2021-10-30

3. Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2019

4. Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data;Journal of the Korean Ophthalmological Society;2019

5. Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema;Journal of the Korean Ophthalmological Society;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3